Innovative solutions to the greatest challenges in pharmaceutical, biologics and device development

The 2023 Summit covers small molecules and biologics, new technologies, innovations and combination products/medical device concepts and case studies in areas such as:

  • Enabling Bioperformance Prediction Through Data Analytics
  • Engineering Prodrug Therapies for Infectious Disease and Cancer Therapy
  • Predictive high-throughput screening of oligonucleotide lipid nanoparticle for gene silencing
  • Targeted delivery of pharmacological agents in the vascular system
  • The evolving paradigm of post-market safety reporting for combination products
  • The Port Delivery System with Ranibizumab: A New Paradigm for Long-Acting Retinal Drug Delivery
  • Current Challenges and Opportunities in Developing Combination Products Biologics Delivery and Medical Devices
  • Development of high-volume wearable drug delivery systems

Speakers 2023

Simone Alidori

GSK

Scientific Leader & Associate Fellow

Jean-Rene Authelin

Sanofi

Senior Scientific Advisor Global CMC

Amey Bandekar

Sanofi

Associate Director - Biologics Drug Product Development & Manufacturing

Alfred Berchielli

Pfizer

Formulation and Process Scientist

Luis Brito

Beam Therapeutics

VP Delivery Platform

Cesar Calero

Sanofi

Senior Scientist Biologics Drug Product Development & Manufacturing

Zhi Chen

Bristol Myers Squibb

Associate Scientific Director

Varsha Dhamankar

Ribon Therapeutics

Director, Head of Formulation Development

James DiNunzio

Merck

Director

Nélio Drumond

Takeda

Associate Director, Lead Process Scientist, Global Manufacturing Sciences, Drug Product

Ajit D'Souza

Kiniksa Pharmaceuticals

Director, Combination Product Development

Keith Faucher

Aura Biosciences

Senior Director Device Development and Innovation

Will Forrest

Merck

Principal Scientist, Sterile & Specialty Products

Sudhakar Garad

Novartis Institutes for BioMedical Research

Global Head of Chemical and Pharmaceutical Profiling 

Yan  He

Sanofi

Head of Early Formulation Development

Alie Jahangir

Janssen

Associate Director, Combination Products & Digital Health

Nitin Joshi

Harvard Medical School

Assistant Professor

Filippos Kesisoglou

Merck

Distinguished Scientist, Pharmaceutical Sciences and Clinical Supply

Shreya Kulkarni

AbbVie Biotherapeutics

Senior Scientist II

Curtis Leung

Agios

Senior Scientist

Dennis  Leung

Genentech

Director and Manager of the Discovery Pharmaceutics and Preformulation

Maya Lipert

Principal Scientist

AbbVie

Rosario LoBrutto

Radius Pharma

Head of Pharmaceutical Sciences and Global Expansion

Xiaofeng Lu

AbbVie

Principal Research Scientist

Suman Luthra

Merck

Director Discovery Pharmaceutical Sciences

Chen Mao

Genentech

Distinguished Scientist, Small Molecule Pharmaceutical Sciences

Gaauri Naik

Relay Therapeutics

Director, Pharmaceutics

Kausik Nanda

Merck

Principal Scientist

Scott Nunn

Gilead

Director, Device Development

Giulio F. Paciotti

CytImmune

Chief Science Officer

Harshil Parikh

Actavis

Principal Scientist Formulations

Steven C. Persak

Merck

Director, Device Development/MRL

Tim Phillips

Cambridge Consultants

Principal Human Factors Engineer

Prof. Michael Sailor

University of California, San Diego

Distinguished Professor of Chemistry and Biochemistry

Manuel Sanchez-Felix

Novartis Institute for BioMedical Research

Associate Director

Harshal Shah

Cambridge Consultants

BioPharma Sector Head

Sheri Shamblin

Pfizer

Director

Anthony Tomlinson

Technical Development Principal Scientist

Genentech

Tina Xiong

Merck

Associate Principal Scientist

Shawn Yin

Bristol-Myers Squibb

Scientific Director

Jun Zhang

Affinivax

Director, Drug Product Formulation and Process Development

Rui Zhang

Tessera Therapeutics

Associate Director

Wei Zhang

Genentech

Principal Scientist, Small Molecule Pharmaceutics